Table 1

Patient characteristics

PatientPET-CT (n=98)CWU (n=91)p Value
Mean age in years (range)62 (42–80)64 (38–80)0.222
Sex (male (%))53 (54)49 (54)0.974
Staging procedures, n (%)
 CT98 (100)91 (100)
 PET-CT84 (86)0 (0)<0.001
 Mediastinoscopy89 (91)88 (97)0.097
 EUS47 (48)35 (38)0.187
 EUS-FNA40 (41)29 (32)0.201
 EBUS8 (8)11 (12)0.368
Histology at operation (n=60/n=73)
 Adenocarcinoma29290.330
 Squamous cell carcinoma2022
 Large cell carcinoma412
 Bronchioalveolar carcinoma01
 NSCLC, other76
 Benign03
Final N stage
 N0–156600.268
 N2–33629
 Nx6*2
Final N stage confirmed by (n)
 Thoracotomy60720.014
 Mediastinoscopy910
 EUS-FNA197
 EBUS-TBNA40
 Not applicable6*2
  • * In 4 patients M1 was found on PET-CT and further confirmation of N stage was not sought. One patient was N0–1, but considered inoperable due to co-existing disease. Explorative thoracotomy was performed in one patient due to inoperable T4 disease; N stage not confirmed.

  • Explorative thoracotomy was performed in two patients due to inoperable T4 disease; N stage not confirmed.

  • CWU, conventional work-up; EBUS, endobronchial ultrasound; EUS, endoscopic ultrasound; FNA, fine needle aspiration; NSCLC, non-small cell lung cancer; PET, positron emission tomography; TBNA, transbronchial needle aspiration.